Medical devices company, Stratec SE (SBS.DE), Thursday announced updates about dividend and financial guidance for the fiscal year 2023.
The company stated its plan to propose dividend of 0.55 euros per share for the financial year 2023, compared to the dividend of 0.97 euros per share in the previous year.
Stratec explained that the decline in dividends is primarily due to internal and potential external growth factors, associated financing requirements, and expenses related to acquisition of Natech Plastics, Inc. in 2023.
The German company said that it has achieved the financial outlook for the fiscal year 2023, with adjusted EBIT level expected to be around 10 percent to 12 percent for the period.
Currently, Stratec's stock is trading at 41.80 euros, up 0.84 percent on the XETRA.
For comments and feedback: editorial@rttnews.com